Characterisation of the Novel HLA ‐ DRB1 *13:371 Allele by Sequencing‐Based Typing
HLA · 2025
DOI: 10.1111/tan.70388 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Isabelle Nel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Histocompatibility Department, Robert-Debré Hospital, AP-HP, Paris, France. Hauptthemen laut MEDLINE: HLA-DRB1 Chains, Alleles, Exons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
The novel allele HLA‐DRB1*13:371 differs from HLA‐DRB1*13:02:01:01 by one nucleotide substitution in codon 127 in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology and Histocompatibility Department, Robert-Debré Hospital, AP-HP, Paris, France.
- University Paris Cité, INSERM UMR1141, Paris, France.
ORCID-Profile: Béatrice Pédron
Zitieren
APA
Nel, I., Pinson, I., Carcelain, G., & Pédron, B. (2025). Characterisation of the Novel HLA ‐ DRB1 *13:371 Allele by Sequencing‐Based Typing. HLA. https://doi.org/10.1111/tan.70388
Vancouver
Nel I, Pinson I, Carcelain G, Pédron B. Characterisation of the Novel HLA ‐ DRB1 *13:371 Allele by Sequencing‐Based Typing. HLA. 2025. doi:10.1111/tan.70388
BibTeX
@article{Nel2025,
author = {Nel, Isabelle and Pinson, Isabelle and Carcelain, Guislaine and Pédron, Béatrice},
title = {Characterisation of the Novel HLA ‐ DRB1 *13:371 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70388}
}
EUVIMED